As Ligand Pharmaceuticals (LGND) Shares Rose, Employees Retirement System Of Texas Raised Holding; Platinum Investment Management LTD Upped Its Seattle Genetics (SGEN) Position

February 22, 2018 - By Nellie Frank

Employees Retirement System Of Texas increased its stake in Ligand Pharmaceuticals Inc (LGND) by 74.38% based on its latest 2017Q3 regulatory filing with the SEC. Employees Retirement System Of Texas bought 9,000 shares as the company’s stock rose 7.66% with the market. The institutional investor held 21,100 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.87M, up from 12,100 at the end of the previous reported quarter. Employees Retirement System Of Texas who had been investing in Ligand Pharmaceuticals Inc for a number of months, seems to be bullish on the $3.24 billion market cap company. The stock decreased 1.69% or $2.64 during the last trading session, reaching $153.7. About 100,882 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has declined 2.87% since February 22, 2017 and is downtrending. It has underperformed by 19.57% the S&P500.

Kerr Neilson increased its stake in Seattle Genetics Inc (SGEN) by 26.56% based on its latest 2017Q3 regulatory filing with the SEC. Platinum Investment Management Ltd bought 8,500 shares as the company’s stock rose 1.68% with the market. The hedge fund run by Kerr Neilson held 40,500 shares of the health care company at the end of 2017Q3, valued at $2.20M, up from 32,000 at the end of the previous reported quarter. Platinum Investment Management Ltd who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $8.53B market cap company. The stock decreased 0.20% or $0.11 during the last trading session, reaching $54. About 298,575 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since February 22, 2017 and is uptrending. It has outperformed by 58.98% the S&P500.




Platinum Investment Management Ltd, which manages about $22.00 billion and $3.96B US Long portfolio, decreased its stake in Baidu Inc (NASDAQ:BIDU) by 871,320 shares to 707,780 shares, valued at $175.31 million in 2017Q3, according to the filing. It also reduced its holding in Callaway Golf Co (NYSE:ELY) by 482,100 shares in the quarter, leaving it with 1.58M shares, and cut its stake in Ebay Inc (NASDAQ:EBAY).

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Seattle Genetics had 64 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, August 29 by Cantor Fitzgerald. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Buy” rating given on Monday, October 23 by Guggenheim. The company was maintained on Monday, September 14 by RBC Capital Markets. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Hold” rating given on Friday, June 2 by Oppenheimer. J.P. Morgan upgraded the shares of SGEN in report on Wednesday, February 14 to “Buy” rating. The rating was maintained by SunTrust with “Hold” on Friday, October 27. The firm has “Neutral” rating given on Monday, December 12 by Credit Suisse. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Hold” rating by Oppenheimer on Thursday, June 15. Barclays Capital downgraded the shares of SGEN in report on Tuesday, November 29 to “Equal-Weight” rating. The stock has “Buy” rating by H.C. Wainwright on Friday, October 27.

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.52, from 1.3 in 2017Q2. It is negative, as 51 investors sold SGEN shares while 74 reduced holdings. 29 funds opened positions while 69 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. Moreover, Macquarie Gp Ltd has 0.01% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 95,917 shares. Hsbc Public Ltd Llc owns 10,614 shares for 0% of their portfolio. Savings Bank Of New York Mellon Corp holds 0.01% or 439,432 shares in its portfolio. Shine Investment Advisory Serv invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Florida-based Carl Domino has invested 0.35% in Seattle Genetics, Inc. (NASDAQ:SGEN). Panagora Asset Mgmt Inc holds 5,341 shares. Creative Planning holds 34,620 shares. Quantbot Technologies Limited Partnership holds 2,654 shares or 0.01% of its portfolio. Proshare Advsr Ltd Liability stated it has 0.04% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Dupont Capital Management holds 7,861 shares or 0.01% of its portfolio. Stifel Finance Corp stated it has 4,196 shares or 0% of all its holdings. Tourbillon Ptnrs Lp holds 1.06% or 805,000 shares. Fmr Limited Liability Co has invested 0.05% in Seattle Genetics, Inc. (NASDAQ:SGEN). Product Prtnrs Ltd Com has invested 0.5% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). 205,111 were reported by Dimensional Fund Advisors Limited Partnership.

Since August 24, 2017, it had 1 insider buy, and 16 insider sales for $189.38 million activity. Another trade for 7,569 shares valued at $397,466 was sold by Cline Darren S. The insider DOBMEIER ERIC sold $1.31M. Another trade for 4,937 shares valued at $236,455 was sold by SIMPSON TODD E. 10,000 shares were sold by HIMES VAUGHN B, worth $532,190 on Friday, September 8. DRACHMAN JONATHAN G sold $475,414 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) on Thursday, August 24. $200.00M worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was bought by BAKER BROS. ADVISORS LP.

Since August 23, 2017, it had 0 insider purchases, and 6 sales for $10.58 million activity. $126,956 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares were sold by Sabba Stephen L. KOZARICH JOHN W sold $362,500 worth of stock or 2,500 shares. $255,980 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares were sold by Aryeh Jason.

Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 24 analyst reports since September 3, 2015 according to SRatingsIntel. On Friday, August 5 the stock rating was downgraded by Deutsche Bank to “Sell”. TH Capital maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) rating on Thursday, November 19. TH Capital has “Buy” rating and $144 target. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Overweight” rating given on Wednesday, April 13 by Stephens. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Hold” rating given on Tuesday, August 8 by Deutsche Bank. As per Wednesday, September 30, the company rating was maintained by TH Capital. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) earned “Buy” rating by H.C. Wainwright on Tuesday, September 5. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Monday, November 13. The company was maintained on Thursday, November 19 by Roth Capital. The company was maintained on Wednesday, November 15 by Craig Hallum. The firm has “Buy” rating given on Wednesday, September 30 by Roth Capital.

Investors sentiment increased to 1.69 in 2017 Q3. Its up 0.45, from 1.24 in 2017Q2. It improved, as 19 investors sold LGND shares while 68 reduced holdings. 50 funds opened positions while 97 raised stakes. 22.76 million shares or 0.86% more from 22.57 million shares in 2017Q2 were reported. Loomis Sayles Company Ltd Partnership holds 0% or 208 shares in its portfolio. Matarin Capital Ltd Liability Corp holds 0.31% or 26,827 shares. State Of New Jersey Common Pension Fund D has invested 0.07% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Farmers And Merchants Invests invested in 60 shares or 0% of the stock. Conestoga Limited Liability Corp, a Pennsylvania-based fund reported 433,125 shares. 72,150 were reported by Prudential Fincl. Granite Partners Limited Liability stated it has 117,396 shares or 0.99% of all its holdings. Fifth Third Bancshares invested in 0% or 4,538 shares. Parallax Volatility Advisers Limited Partnership owns 8,585 shares for 0% of their portfolio. Grp Inc One Trading Lp holds 3,442 shares. Hightower Ltd Liability reported 0.01% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). New York-based Pinebridge Invs Limited Partnership has invested 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Amalgamated Retail Bank invested in 2,822 shares or 0.01% of the stock. Etrade Capital Management Limited Company invested 0.04% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Macquarie Grp stated it has 463,035 shares.

Employees Retirement System Of Texas, which manages about $7.64 billion US Long portfolio, decreased its stake in Ambev Sa (NYSE:ABEV) by 93,300 shares to 380,200 shares, valued at $2.51 million in 2017Q3, according to the filing. It also reduced its holding in Interxion Holding N.V (NYSE:INXN) by 103,000 shares in the quarter, leaving it with 63,000 shares, and cut its stake in Discovery Communicatns New (NASDAQ:DISCK).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.